Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy

Medicinal Research Reviews
Changmai ChenXinjing Tang

Abstract

Gene-based therapy is one of essential therapeutic strategies for precision medicine through targeting specific genes in specific cells of target tissues. However, there still exist many problems that need to be solved, such as safety, stability, selectivity, delivery, as well as immunity. Currently, the key challenges of gene-based therapy for clinical potential applications are the safe and effective nucleic acid drugs as well as their safe and efficient gene delivery systems. In this review, we first focus on current nucleic acid drugs and their formulation in clinical trials and on the market, including antisense oligonucleotide, siRNA, aptamer, and plasmid nucleic acid drugs. Subsequently, we summarize different chemical modifications of nucleic acid drugs as well as their delivery systems for gene-based therapeutics in vivo based on nucleic acid chemistry and nanotechnology methods.

References

Apr 8, 1999·Drugs·C M Perry, J A Balfour
Apr 2, 2004·Nature Reviews. Immunology·Dennis M Klinman
Sep 17, 2004·Nature·Gunter Meister, Thomas Tuschl
Nov 3, 2004·Nucleic Acids Research·Raymond M SchiffelersMartin C Woodle
Nov 13, 2004·Nature·Jürgen SoutschekHans-Peter Vornlocher
Jan 19, 2005·The Journal of Investigative Dermatology·Julianna LisziewiczFranco Lori
Jul 26, 2005·Nature Biotechnology·David V MorrisseyBarry Polisky
Nov 1, 2005·Nature·Jan KrützfeldtMarkus Stoffel
Jan 18, 2006·Pharmaceutical Research·Thomas G McCauleyH Nicholas Marsh
Mar 21, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chunling ZhangVladimir P Torchilin
Mar 28, 2006·Nature·Tracy S ZimmermannIan MacLachlan
Jun 3, 2006·Nucleic Acids Research·Ted C ChuMatthew Levy
Jul 11, 2006·Nature Biotechnology·James O McNamaraPaloma H Giangrande
Feb 17, 2007·Nature Reviews. Genetics·Daniel H Kim, John J Rossi
Jun 2, 2007·Nature Reviews. Drug Discovery·Antonin de FougerollesJudy Lieberman
Jul 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·David B RozemaJon A Wolff
Sep 12, 2007·Nature Reviews. Genetics·Alexander Serganov, Dinshaw J Patel
Sep 18, 2007·Nature Biotechnology·Christian WolfrumMarkus Stoffel
Mar 26, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kazutaka NishinaTakanori Yokota
Mar 28, 2008·Nucleic Acids Research·Md Rowshon AlamRudy L Juliano
Apr 29, 2008·Nature Biotechnology·Stephen C HydeDeborah R Gill
May 20, 2008·Drugs·Aimee V Chappelow, Peter K Kaiser
Jun 12, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Natee JearawiriyapaisarnRyszard Kole
Aug 5, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sumio ChonoLeaf Huang
Sep 9, 2008·Nucleic Acids Symposium Series·Christian MaaschSven Klussmann
Nov 22, 2008·Pharmaceutical Research·Sherry Y WuNigel A J McMillan
Dec 5, 2008·Bioconjugate Chemistry·Ji Hoon JeongTae Gwan Park
Jan 23, 2009·Nature·Haruhiko Siomi, Mikiko C Siomi
Nov 26, 2009·Journal of the American Chemical Society·Marc NothisenJean-Paul Behr
Nov 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sancy A LeachmanRoger L Kaspar
Apr 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·John DeVincenzoAkshay Vaishnaw
Jul 2, 2010·Nature Reviews. Drug Discovery·Anthony D KeefeAndrew Ellington
Sep 23, 2010·Nano Letters·Ryan HuschkaNaomi J Halas
Nov 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ansgar SantelJörg Kaufmann
Dec 17, 2010·Nature Reviews. Cancer·Chad V PecotAnil K Sood
Dec 28, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Soo Hyeon LeeTae Gwan Park
Apr 29, 2011·Gene Therapy·J A Broderick, P D Zamore

❮ Previous
Next ❯

Citations

Jun 19, 2018·Annals of Medicine·Irene Marafini, Giovanni Monteleone
Sep 25, 2018·Expert Opinion on Drug Delivery·Simone Hager, Ernst Wagner
Mar 29, 2019·Journal of Cellular Physiology·Shahin AghamiriBabak Negahdari
Apr 4, 2019·Chemistry : a European Journal·Mick HornumPoul Nielsen
Jul 4, 2019·Chemical Communications : Chem Comm·Ana I Carbajo-GordilloJosé M García Fernández
Dec 28, 2018·Nucleic Acids Research·Anita KotarJanez Plavec
Feb 7, 2020·PloS One·Yota TaniguchiShigeru Kawakami
Apr 14, 2020·Expert Opinion on Drug Delivery·Shahin AghamiriHossein Ghanbarian
Nov 9, 2018·International Journal of Molecular Sciences·Agnieszka B OlejniczakZbigniew J Leśnikowski
May 21, 2019·Frontiers in Pharmacology·Ivan V ChernikovElena L Chernolovskaya
Jul 2, 2020·Biologics : Targets & Therapy·Irene Marafini, Giovanni Monteleone
May 10, 2019·Frontiers in Oncology·Reena GoswamiVenkaiah Betapudi
Sep 17, 2020·Organic & Biomolecular Chemistry·Alaa S GoudaJesper Wengel
Oct 8, 2020·Nucleic Acid Therapeutics·Suxiang ChenRakesh N Veedu
Jul 2, 2019·International Journal of Pharmaceutics·Marimuthu CitartanThean-Hock Tang
Jan 28, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Can LeiTao Zou
Jan 30, 2021·Biochemical Pharmacology·M May ZhangXiao-Bo Zhong
Oct 7, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wenxing GuZhiyuan Zhong
Mar 2, 2021·Chemical Society Reviews·Luke K McKenzieMarcel Hollenstein
Jul 30, 2021·Advanced Drug Delivery Reviews·Yaping Zhuang, Wenguo Cui
Aug 2, 2021·Molecular Aspects of Medicine·Manish PandeyGeetanjali Chawla
Sep 10, 2020·Molecular Pharmaceutics·Prabhjeet SinghDeepak Chitkara
Apr 10, 2019·Journal of the American Chemical Society·Quanbing MouChuan Zhang
Mar 9, 2021·ACS Applied Bio Materials·Tingting ShenGuizhi Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.